The Role of Mast Cells in the Development and Advancement of Endometriosis

Endometriosis is a medical condition identified by the presence of endometrium-like tissue outside the uterus. This condition is known to result in symptoms such as frequent pelvic pain, infertility, and irregularities in the menstrual cycle. The development of endometriosis is complex and, involving abnormal body responses, hormonal imbalances, and genetic predispositions. Although endometriosis is common and affects quality of life, its mechanisms of development and progression are not fully understood. Mast cells (MCs), a type of immune cell, are renowned for their involvement in allergic and inflammatory responses. These cells are essential in the modulation of the immune system and the inflammatory process through the secretion of different mediators like histamine, cytokines, and proteases. In recent years, MCs have been shown to play a role in the pathogenesis of many diseases, including endometriosis. This article explores the relationship between MCs and endometriosis, including disease development, pain perception, angiogenesis, and other important processes. It elucidates how MCs, via their mediators, actively participate in the pathogenesis of endometriosis and the associated inflammatory environment. Moreover, the research emphasizes the potential of targeting MCs as a therapeutic approach for treating endometriosis. Insight into the interplay between endometriosis and MCs holds promise for developing innovative therapeutic strategies to manage this condition effectively. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement Research data are not shared.

- 1G. C. Tan, Y. P. Wong, and T. Y. Khong. “ Menstrual Cycle of Endometrium,” in Gynecologic and Obstetric Pathology, eds. W. Zheng, O. Fadare, and C. M. Quick (Singapore: Springer Nature Singapore, 2024), 1–30. 10.1007/978-981-19-7696-4_55-1Google Scholar - 2D. A. Gibson, I. Simitsidellis, F. Collins, and P. T. K. Saunders, “Androgens, Oestrogens and Endometrium: A Fine Balance Between Perfection and Pathology,” Journal of Endocrinology 246, no. 3 (2020), R75–R93. - 3B. A. Lessey and S. L. Young. “ Structure, Function, and Evaluation of the Female Reproductive Tract,” in Yen and Jaffe's Reproductive Endocrinology, eds. J. F. Strauss and R. L. Barbieri, 8th ed. (Philadelphia: Elsevier, 2019), 206–247.e13. 10.1016/B978-0-323-47912-7.00009-3Google Scholar - 4C. R. Wira, M. Rodríguez-García, Z. Shen, and M. V. Patel. “ Chapter 10 - Endocrine Control of Mucosal Immunity in the Human Female Reproductive Tract: Bridging Implantation With Pathogen Protection,” in Reproductive Immunology, ed. G. Mor (Academic Press, 2021), 171–206. 10.1016/B978-0-12-818508-7.00013-0Google Scholar - 5J. Vallvé-Juanico, S. Houshdaran, and L. C. Giudice. “The Endometrial Immune Environment of Women With Endometriosis,” Human Reproduction Update 25, no. 5 (Oxford University Press, 2019): 565–592. - 6A. McCallion, Y. Nasirzadeh, H. Lingegowda et al., “Estrogen Mediates Inflammatory Role of Mast Cells in Endometriosis Pathophysiology,” Frontiers in Immunology 13 (2022): 961599. - 7Y. Li, S. Cui, Z. Xu et al., “Exosomal tRF-Leu-AAG-001 Derived From Mast Cell as a Potential Non-Invasive Diagnostic Biomarker for Endometriosis,” BMC Womens Health 22, no. 1 (2022): 253. - 8G. A. Aydin, H. Ayvaci, N. Koc, N. Tarhan, and O. Demirci, “The Relationship Between Decorin and VEGF in Endometriosis,” Journal of the College of Physicians and Surgeons–Pakistan 31, no. 11 (2021): 1285–1290. - 9K. N. Insaniyah, A. Sa'adi, and W. Widjiati, “Impact of EThanol Extract of Basil Leaves (Ocimum basilicum L.) on Mast Cell Reduction and Prostaglandin E2 Levels in Female Mice as a Model for Endometriosis Development,” Journal of Medicinal and Chemical Sciences 6, no. 12 (2023): 2941–2951. - 10A. M. I. Ofiteru, S. Berceanu, S. Paitici et al., “Endometriosis of the Abdominal Wall—Clinical, Histopathological and Immunohistochemical Aspects,” Revista De Chimie 70, no. 8 (2019): 2860–2865. - 11D. Szukiewicz, “Insight Into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis,” International Journal of Molecular Sciences 24, no. 15 (2023): 12195. - 12A. M. Istrate-Ofiţeru, E. I. Berbecaru, G. L. Zorilă et al., “Specific Local Predictors That Reflect the Tropism of Endometriosis-A Multiple Immunohistochemistry Technique,” International Journal of Molecular Sciences 23, no. 10 (2022): 5614. - 13L. Cacciottola, J. Donnez, and M. M. Dolmans, “Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?,” International Journal of Molecular Sciences 22, no. 13 (2021): 7138. - 14S. G. Powell, P. Sharma, S. Masterson et al., “Vascularisation in Deep Endometriosis: A Systematic Review With Narrative Outcomes,” Cells 12, no. 9 (2023): 1318. - 15I. Jakson, A. L. Hirschberg, and S. B. Gidlöf, “Endometriosis and Menopause—Management Strategies Based on Clinical Scenarios,” Acta Obstetricia Et Gynecologica Scandinavica 102, no. 10 (2023): 1323–1328. - 16L. B. Afrin, “Mast Cell Activation Disease and the Modern Epidemic of Chronic Inflammatory Disease,” Translational Research 174 (2016): 33–59. - 17V. Pergialiotis, M. Fanaki, I. Bellos, K. Stefanidis, D. Loutradis, and G. Daskalakis, “The Impact of Vascular Endothelial Growth Factor Single Nucleotide Polymorphisms in the Development and Severity of Endometriosis: A Systematic Review of the Literature,” Journal of Gynecology Obstetrics and Human Reproduction 49, no. 10 (2020): 101732. - 18D. Zhao, Q. Bao, L. Chen, and L. Zheng, “Effects of SU5416 on Angiogenesis and the ERK-VEGF/MMP-9 Pathway in Rat Endometriosis,” Investigación Clínica 64, no. 4 (2023): 482–494. - 19S. Kamrani, E. Amirchaghmaghi, F. Ghaffari, M. Shahhoseini, and K. Ghaedi, “Altered Gene Expression of VEGF, IGFs and H19 lncRNA and Epigenetic Profile of H19-DMR Region in Endometrial Tissues of Women With Endometriosis,” Reproductive Health 19, no. 1 (2022): 100. - 20D. Q. A'Yuni, A. Sa'adi, and W. Widjiati, “EThanol Extract of Basil (Ocimum Basilicum L.) Leaves Inhibits Endometriosis Growth in a Mouse Model by Modulating Vascular Endothelial Growth Factor (VEGF) Expression,” Journal of Medicine and Life 16, no. 8 (2023): 1224–1230. - 21O. A. Babah, O. O. Ojewunmi, A. A. Osuntoki, M. A. Simon, and B. B. Afolabi, “Genetic Polymorphisms of Vascular Endothelial Growth Factor (VEGF) Associated With Endometriosis in Nigerian Women,” Human Genomics 15, no. 1 (2021): 64. - 22R. Di Paola, R. Fusco, E. Gugliandolo et al., “Co-Micronized PalmitoyleThanolamide/Polydatin Treatment Causes Endometriotic Lesion Regression in a Rodent Model of Surgically Induced Endometriosis,” Frontiers in Pharmacology 7 (2016): 382. - 23L. Gan, J. Sun, and J. Sun, “Bioinformatical Analysis Identifies PDLIM3 as a Potential Biomarker Associated With Immune Infiltration in Patients With Endometriosis,” PeerJ 10 (2022): e13218. - 24T. C. Theoharides and J. M. Stewart, “Genitourinary Mast Cells and Survival,” Translational Andrology and Urology 4, no. 5 (2015): 579–586. - 25M. Cuevas, I. Flores, K. J. Thompson, D. L. Ramos-Ortolaza, A. Torres-Reveron, and C. B. Appleyard, “Stress Exacerbates Endometriosis Manifestations and Inflammatory Parameters in an Animal Model,” Reproductive Sciences 19, no. 8 (2012): 851–862. - 26A. Arangia, Y. Marino, R. Fusco et al., “Fisetin, a Natural Polyphenol, Ameliorates Endometriosis Modulating Mast Cells Derived NLRP-3 Inflammasome Pathway and Oxidative Stress,” International Journal of Molecular Sciences 24, no. 6 (2023): 5076. - 27T. Li, J. Wang, X. Guo et al., “Possible Involvement of Crosstalk Between Endometrial Cells and Mast Cells in the Development of Endometriosis via CCL8/CCR1,” Biomedicine & Pharmacotherapy 129 (2020): 110476. - 28T. Arablou, N. Aryaeian, S. Khodaverdi et al., “The Effects of Resveratrol on the Expression of VEGF, TGF-β, and MMP-9 in Endometrial Stromal Cells of Women With Endometriosis,” Scientific Reports 11, no. 1 (2021): 6054. - 29C. Agostinis, S. Zorzet, A. Balduit et al., “The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis,” Frontiers in Immunology 12 (2021): 693118. - 30Y. Yu, H. M. Chang, and J. E. Schjenken, “Editorial: Reproduction and the Inflammatory Response,” Frontiers in Endocrinology (Lausanne) 12 (2021): 835854. - 31R. Fusco, R. D'Amico, M. Cordaro et al., “Absence of Formyl Peptide Receptor 1 Causes Endometriotic Lesion Regression in a Mouse Model of Surgically-Induced Endometriosis,” Oncotarget 9, no. 59 (2018): 31355–31366. - 32W. Windarti, A. Sa'adi, and W. Widjiati, “Correlation Between Vitamin D Administration and Reduced Expression of VEGF and MMP-9 in Abnormal Endometrial Stroma (Experimental in Mice Models With Endometriosis),” Journal of Medicinal and Chemical Sciences 6, no. 12 (2023): 2952–2963. - 33H. Sauqi, B. Santoso, W. Widjiati, and H. Hendarto, “Red Fruit (Pandanus conoideus) Inhibits the Development of Endometriosis Lesions Through Downregulation of NF-kB and VEGF Expression,” Rawal Medical Journal 45, no. 4 (2020): 985–989. - 34E. Crivellato, C. A. Beltrami, F. Mallardi, and D. Ribatti, “The Mast Cell: An Active Participant or an Innocent Bystander?,” Histology and Histopathology 19, no. 1 (2004): 259–270. - 35K. Amin, “The Role of Mast Cells in Allergic Inflammation,” Respiratory Medicine 106, no. 1 (2012): 9–14. - 36M. Krystel-Whittemore, K. N. Dileepan, and J. G. Wood, “Mast Cell: A Multi-Functional Master Cell,” Frontiers in Immunology 6 (2015): 620. - 37S. Tikoo, N. Barki, R. Jain et al., “Imaging of Mast Cells,” Immunological Reviews 282, no. 1 (2018): 58–72. - 38J. Baran, A. Sobiepanek, A. Mazurkiewicz-Pisarek et al., “Mast Cells as a Target-A Comprehensive Review of Recent Therapeutic Approaches,” Cells 12, no. 8 (2023): 1187. - 39S. J. Galli, N. Gaudenzio, and M. Tsai, “Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns,” Annual Review of Immunology 38 (2020): 49–77. - 40J. Vallvé-Juanico, S. Houshdaran, and L. C. Giudice, “The Endometrial Immune Environment of Women With Endometriosis,” Human Reproduction Update 25, no. 5 (2019): 564–591. - 41J. S. Dahlin, M. Maurer, D. D. Metcalfe, G. Pejler, R. Sagi-Eisenberg, and G. Nilsson, “The Ingenious Mast Cell: Contemporary Insights Into Mast Cell Behavior and Function,” Allergy 77, no. 1 (2022): 83–99. - 42S. Bais, R. Kumari, Y. Prashar, and N. S. Gill, “Review of Various Molecular Targets on Mast Cells and its Relation to Obesity: A Future Perspective,” Diabetes & Metabolic Syndrome 11, no. Suppl 2 (2017): S1001–S1007. - 43D. D. Metcalfe, D. Baram, and Y. A. Mekori, “Mast Cells,” Physiological Reviews 77, no. 4 (1997): 1033–1079. - 44D. Elieh Ali Komi, S. Wöhrl, and L. Bielory, “Mast Cell Biology at Molecular Level: A Comprehensive Review,” Clinical Reviews in Allergy & Immunology 58, no. 3 (2020): 342–365. - 45A. M. Gilfillan, S. J. Austin, and D. D. Metcalfe, “Mast Cell Biology: Introduction and Overview,” Advances in Experimental Medicine and Biology 716 (2011): 2–12. - 46T. C. Moon, A. D. Befus, and M. Kulka, “Mast Cell Mediators: Their Differential Release and the Secretory Pathways Involved,” Frontiers in Immunology 5 (2014): 569. - 47G. J. Molderings and L. B. Afrin, “A Survey of the Currently Known Mast Cell Mediators With Potential Relevance for Therapy of Mast Cell-Induced Symptoms,” Naunyn-Schmiedeberg's Archives of Pharmacology 396, no. 11 (2023): 2881–2891. - 48A. Niarakis and M. Daëron. “ Activating and Inhibitory Receptors on Mast Cells,” in Encyclopedia of Medical Immunology: Allergic Diseases, eds. I. R. Mackay, N. R. Rose, D. K. Ledford, and R. F. Lockey (New York, NY: Springer New York, 2014), 1–10. 10.1007/978-1-4614-9194-1_92Google Scholar - 49H. Migalovich-Sheikhet, S. Friedman, D. Mankuta, and F. Levi-Schaffer, “Novel Identified Receptors on Mast Cells,” Frontiers in Immunology 3 (2012): 238. - 50J. Agier, J. Pastwińska, and E. Brzezińska-Błaszczyk, “An Overview of Mast Cell Pattern Recognition Receptors,” Inflammation Research 67, no. 9 (2018): 737–746. - 51M. M. Binda, J. Donnez, and M. M. Dolmans, “Targeting Mast Cells: A New Way to Treat Endometriosis,” Expert Opinion on Therapeutic Targets 21, no. 1 (2017): 67–75. - 52C. Agostinis, A. Mangogna, F. Bossi, G. Ricci, U. Kishore, and R. Bulla, “Uterine Immunity and Microbiota: A Shifting Paradigm,” Frontiers in Immunology 10 (2019): 2387. - 53X. Guo, X. Xu, T. Li et al., “NLRP3 Inflammasome Activation of Mast Cells by Estrogen via the Nuclear-Initiated Signaling Pathway Contributes to the Development of Endometriosis,” Frontiers in Immunology 12 (2021): 749979. - 54S. K. Godin, J. Wagner, P. Huang, and D. Bree, “The Role of Peripheral Nerve Signaling in Endometriosis,” FASEB BioAdvances 3, no. 10 (2021): 802–813. - 55D. A. Hart, “Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?,” International Journal of Inflammation 2015 (2015): 452095. - 56N. Lampiasi, “Interactions Between Macrophages and Mast Cells in the Female Reproductive System,” International Journal of Molecular Sciences 23, no. 10 (2022): 5414. - 57H. Fujiwara, R. Konno, S. Netsu et al., “Localization of Mast Cells in Endometrial Cysts,” American Journal of Reproductive Immunology 51, no. 5 (2004): 341–344. - 58D. Kirchhoff, S. Kaulfuss, U. Fuhrmann, M. Maurer, and T. M. Zollner, “Mast Cells in Endometriosis: Guilty or Innocent Bystanders?,” Expert Opinion on Therapeutic Targets 16, no. 3 (2012): 237–241. - 59V. Borelli, M. Martinelli, S. Luppi et al., “Mast Cells in Peritoneal Fluid From Women With Endometriosis and Their Possible Role in Modulating Sperm Function,” Frontiers in Physiology 10 (2019): 1543. - 60S. Bacci, J. M. Brown, and D. Ribatti, “Editorial: Mast Cells in Health, Disease and Forensic Practice: A Mystery Not yet Revealed,” Frontiers of Medicine (Lausanne) 10 (2023): 1288565. - 61I. E. Oală, M. I. Mitranovici, D. M. Chiorean et al., “Endometriosis and the Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Pathophysiology: A Narrative Review of the Literature,” Diagnostics (Basel) 14, no. 3 (2024): 312. - 62M. Sugamata, T. Ihara, and I. Uchiide, “Increase of Activated Mast Cells in Human Endometriosis,” American Journal of Reproductive Immunology 53, no. 3 (2005): 120–125. - 63G. Zou, J. Wang, X. Xu et al., “Cell Subtypes and Immune Dysfunction in Peritoneal Fluid of Endometriosis Revealed by Single-Cell RNA-Sequencing,” Cell & Bioscience 11, no. 1 (2021): 98. - 64S. Matsuzaki, M. Canis, C. Darcha, T. Fukaya, A. Yajima, and M. A. Bruhat, “Increased Mast Cell Density in Peritoneal Endometriosis Compared With Eutopic Endometrium With Endometriosis,” American Journal of Reproductive Immunology 40, no. 4 (1998): 291–294. - 65R. Konno, H. Yamada-Okabe, H. Fujiwara et al., “Role of Immunoreactions and Mast Cells in Pathogenesis of Human Endometriosis–Morphologic Study and Gene Expression Analysis,” Human Cell 16, no. 3 (2003): 141–149. - 66S. Tsuji, K. Tsuji, H. Otsuka, and T. Murakami, “Increased Mast Cells in Endocervical Smears of Women With Dysmenorrhea,” CytoJournal 15 (2018): 27. - 67R. Paula Jr, A. H. Oliani, D. C. Vaz-Oliani, S. C. D'Ávila, S. M. Oliani, and C. D. Gil, “The Intricate Role of Mast Cell Proteases and the Annexin A1-FPR1 System in Abdominal Wall Endometriosis,” Journal of Molecular Histology 46, no. 1 (2015): 33–43. - 68G. F. Meresman, M. Götte, and M. W. Laschke, “Plants as Source of New Therapies for Endometriosis: A Review of Preclinical and Clinical Studies,” Human Reproduction Update 27, no. 2 (2021): 367–392. - 69K. Q. Lin, L. B. Zhu, X. M. Zhang, and J. Lin, “Role of Mast Cells in Estrogen-Mediated Experimental Endometriosis in Rats,” Zhejiang Da Xue Xue Bao Yi Xue Ban = Journal of Zhejiang University Medical Sciences 44, no. 3 (2015): 269–277. - 70X. Xu, J. Wang, X. Guo et al., “GPR30-Mediated Non-Classic Estrogen Pathway in Mast Cells Participates in Endometriosis Pain via the Production of FGF2,” Frontiers in Immunology 14 (2023): 1106771. - 71F. Yang, Y. Yu, and H. Liu, “Mechanism of Action of Yikun Yitong Ping-Containing Serum on Mast Cells and Its Possible Involvement in Endometriosis-Related Dysmenorrhea,” Natural Product Communications 19, no. 2 (2024): 1934578×241229929. - 72Q. Zhong, F. Yang, X. Chen, J. Li, C. Zhong, and S. Chen, “Patterns of Immune Infiltration in Endometriosis and Their Relationship to R-AFS Stages,” Frontiers in Genetics 12 (2021): 631715. - 73C. Xie, C. Lu, Y. Liu, and Z. Liu, “Diagnostic Gene Biomarkers for Predicting Immune Infiltration in Endometriosis,” BMC Womens Health 22, no. 1 (2022): 184. - 74Y. Osuga, “Current Concepts of the Pathogenesis of Endometriosis,” Reproductive Medicine and Biology 9, no. 1 (2010): 1–7. - 75D. Szukiewicz, P. Wojdasiewicz, M. Watroba, and G. Szewczyk, “Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence,” Journal of Immunology Research 2022 (2022): 9534163. - 76W. J. Zhou, H. L. Yang, J. Shao et al., “Anti-Inflammatory Cytokines in Endometriosis,” Cellular and Molecular Life Sciences 76, no. 11 (2019): 2111–2132. - 77H. F. Bungum, U. Nygaard, C. Vestergaard, P. M. Martensen, and U. B. Knudsen, “Increased IL-25 Levels in the Peritoneal Fluid of Patients With Endometriosis,” Journal of Reproductive Immunology 114 (2016): 6–9. - 78O. J. D'Cruz and F. M. Uckun, “Targeting Mast Cells in Endometriosis With Janus Kinase 3 Inhibitor, JANEX-1,” American Journal of Reproductive Immunology 58, no. 2 (2007): 75–97. - 79I. B. L. de Barros, H. Malvezzi, B. Y. Gueuvoghlanian-Silva, C. A. Piccinato, L. V. Rizzo, and S. Podgaec, ““What Do We Know About Regulatory T Cells and Endometriosis? A Systematic Review”,” Journal of Reproductive Immunology 120 (2017): 48–55. - 80L. Mariuzzi, R. Domenis, M. Orsaria et al., “Functional Expression of Aryl Hydrocarbon Receptor on Mast Cells Populating human Endometriotic Tissues,” Laboratory Investigation 96, no. 9 (2016): 959–971. - 81M. Krystel-Whittemore, K. N. Dileepan, and J. G. Wood, “Mast Cell: A Multi-Functional Master Cell,” Frontiers in Immunology 6 (2016): 620. - 82Y. Wei, Y. Liang, H. Lin, Y. Dai, and S. Yao, “Autonomic Nervous System and Inflammation Interaction in Endometriosis-Associated Pain,” Journal of Neuroinflammation 17, no. 1 (2020): 80. - 83D. Atiakshin, O. Patsap, A. Kostin, L. Mikhalyova, I. Buchwalow, and M. Tiemann, “Mast Cell Tryptase and Carboxypeptidase A3 in the Formation of Ovarian Endometrioid Cysts,” International Journal of Molecular Sciences 24, no. 7 (2023): 6498. - 84H.-L. Yang, M.-Q. Li, and Y.-Q. Zhu, “Indoleamine 2,3-Dioxygenase in Endometriosis,” Reproductive and Developmental Medicine 03, no. 02 (2019): 110–116. 10.4103/2096-2924.262391Google Scholar - 85V. Anaf, C. Chapron, I. El Nakadi, V. De Moor, T. Simonart, and J. C. Noël, “Pain, Mast Cells, and Nerves in Peritoneal, Ovarian, and Deep Infiltrating Endometriosis,” Fertility and Sterility 86, no. 5 (2006): 1336–1343. - 86C. Agostinis, A. Balduit, A. Mangogna et al., “Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target,” Frontiers in Immunology 11 (2020): 599117. - 87A. Aich, L. B. Afrin, and K. Gupta, “Mast Cell-Mediated Mechanisms of Nociception,” International Journal of Molecular Sciences 16, no. 12 (2015): 29069–29092. - 88T. H. Zhu, S. J. Ding, T. T. Li, L. B. Zhu, X. F. Huang, and X. M. Zhang, “Estrogen Is an Important Mediator of Mast Cell Activation in Ovarian Endometriomas,” Reproduction (Cambridge, England) 155, no. 1 (2018): 73–83. - 89T. Genovese, M. Cordaro, R. Siracusa et al., “Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated With Endometriosis,” International Journal of Molecular Sciences 23, no. 10 (2022): 5427. - 90D. P. Green, N. Limjunyawong, N. Gour, P. Pundir, and X. Dong, “A Mast-Cell-Specific Receptor Mediates Neurogenic Inflammation and Pain,” Neuron 101, no. 3 (2019): 412–420.e3. - 91J. Cheng, C. Li, Y. Ying et al., “Metformin Alleviates Endometriosis and Potentiates Endometrial Receptivity via Decreasing VEGF and MMP9 and Increasing Leukemia Inhibitor Factor and HOXA10,” Frontiers in Pharmacology 13 (2022): 750208. - 92E. Novella-Maestre, S. Herraiz, J. M. Vila-Vives, C. Carda, A. Ruiz-Sauri, and A. Pellicer, “Effect of Antiangiogenic Treatment on Peritoneal Endometriosis-Associated Nerve Fibers,” Fertility and Sterility 98, no. 5 (2012): 1209–1217. - 93D. E. A. Komi, K. Khomtchouk, and P. L. Santa Maria, “A Review of the Contribution of Mast Cells in Wound Healing: Involved Molecular and Cellular Mechanisms,” Clinical Reviews in Allergy & Immunology 58, no. 3 (2020): 298–312. - 94M. Khodarahmian, F. Amidi, A. Moini et al., “A Randomized Exploratory Trial to Assess the Effects of Resveratrol on VEGF and TNF-α 2 Expression in Endometriosis Women,” Journal of Reproductive Immunology 143 (2021): 103248. - 95I. Mulyantoro, N. P. Noerpramana, Y. Heru Febrianto et al., “Effect of Adipose-Derived Mesenchymal Stem Cell on the Expressions of Bax/Bcl-2, Ki67, VEGF, TNF-α, and Endometrial Implants in Metformin-Administered Endometriosis Mice (A Mouse Model in Endometriosis Study),” Turkish Journal of Immunology 9, no. 1 (2021): 36–49. - 96A. M. Istrate-Ofiţeru, C. A. Mogoantă, G. L. Zorilă et al., “Clinical Characteristics and Local Histopathological Modulators of Endometriosis and Its Progression,” International Journal of Molecular Sciences 25, no. 3 (2024): 1789. - 97M. Cuevas, M. L. Cruz, A. E. Ramirez et al., “Stress During Development of Experimental Endometriosis Influences Nerve Growth and Disease Progression,” Reproductive Sciences 25, no. 3 (2018): 347–357. - 98D. Kempuraj, N. Papadopoulou, E. J. Stanford et al., “Increased Numbers of Activated Mast Cells in Endometriosis Lesions Positive for Corticotropin-Releasing Hormone and Urocortin,” American Journal of Reproductive Immunology 52, no. 4 (2004): 267–275. - 99T. H. Zhu, G. Zou, S. J. Ding et al., “Mast Cell Stabilizer Ketotifen Reduces Hyperalgesia in a Rodent Model of Surgically Induced Endometriosis,” Journal of Pain Research 12 (2019): 1359–1369. - 100T. Iuvone, G. Affaitati, D. De Filippis et al., “Ultramicronized PalmitoyleThanolamide Reduces Viscerovisceral Hyperalgesia in a Rat Model of Endometriosis Plus Ureteral Calculosis: Role of Mast Cells,” Pain 157, no. 1 (2016): 80–91. - 101S. L. Engemise, J. M. Willets, J. O. Emembolu, and J. C. Konje, “The Effect of the Levonorgestrel-Releasing Intrauterine System, Mirena on Mast Cell Numbers in Women With Endometriosis Undergoing Symptomatic Treatment,” European Journal of Obstetrics, Gynecology, and Reproductive Biology 159, no. 2 (2011): 439–442. - 102L. B. Zhu, K. Q. Lin, X. M. Zhang, and J. Lin, “Sodium Cromoglycate Attenuates Experimental Endometriosis in Rats by Regulating Mast Cells,” Zhejiang Da Xue Xue Bao Yi Xue Ban = Journal of Zhejiang University Medical Sciences 44, no. 3 (2015): 278–284. - 103R. Tapdıgova, G. Bayrak, B. C. Yılmaz, and H. Aytan, “Antilipidemic Ezetimibe Induces Regression of Endometriotic Explants in a Rat Model of Endometriosis With Its Anti-Inflammatory and Anti-Angiogenic Effects,” Naunyn-Schmiedebergs Archives of Pharmacology 395, no. 6 (2022): 673–680. - 104Q. Yu, L. Chen, J. Wang et al., “Investigation of the Therapeutic Effect of Salbutamol on Endometriosis in a Mouse Model,” Reproductive Sciences 31, no. 2 (2024): 430–440. - 105M. Cordaro, A. Trovato Salinaro, R. Siracusa et al., “Hidrox and Endometriosis: Biochemical Evaluation of Oxidative Stress and Pain,” Antioxidants (Basel) 10, no. 5 (2021): 720. - 106E. Jankovich and A. Watkins, “The Low FODMAP Diet Reduced Symptoms in a Patient With Endometriosis and IBS,” South African Journal of Clinical Nutrition 30, no. 4 (2017): 32–36. Citing Literature Article Metrics Total unique accesses to an article’s full text in HTML or PDF/ePDF format.More metric information Scite metrics Explore this article's citation statements on scite.ai Share QR Code Generating QR code QR code copied to clipboard! Something went wrong while generating your QR code. Please try again in a moment. If the issue persists, refresh the page or contact support. Export citation Unable to load citation data. Please try again in a moment. How to cite Elkins, L. J., & Spiegelman, M. (2021). pyUserCalc: A revised Jupyter notebook calculator for uranium-series disequilibria in basalts. Earth and Space Science, 8, e2020EA001619. https://doi.org/10.1029/2020EA001619 Download Citation If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click on download. This feature enables you to download the bibliographic information (also called citation data, header data, or metadata) for the articles on our site. Citation manager file format Use the dropdown list to choose how to format the bibliographic data you're harvesting. Several citation manager formats are available, including EndNote and BibTex. You can then copy the formatted citation (as displayed) or download it as file, to your device. If the RefWorks format is chosen, the 'Download' button will be replaced with an option to directly export to RefWorks